InspireMD, Inc. (NSPR)
NSPR Stock Price Chart
Explore InspireMD, Inc. interactive price chart. Choose custom timeframes to analyze NSPR price movements and trends.
NSPR Company Profile
Discover essential business fundamentals and corporate details for InspireMD, Inc. (NSPR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
12 Apr 2011
Employees
85.00
Website
https://www.inspiremd.comCEO
Marvin L. Slosman
Description
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system for use in carotid artery applications; and MGuard Prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions, as well as bypass surgery. It is also developing PVGuard, a MicroNet mesh sleeve and self-expandable stent for use in peripheral vascular applications. The company sells its products through local distributors. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.
NSPR Financial Timeline
Browse a chronological timeline of InspireMD, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 10 Mar 2026
Upcoming earnings on 11 Nov 2025
EPS estimate is -$0.17.
Earnings released on 4 Aug 2025
EPS came in at -$0.26 falling short of the estimated -$0.24 by -8.33%, while revenue for the quarter reached $1.78M , beating expectations by +1.05%.
Earnings released on 9 May 2025
EPS came in at -$0.22 falling short of the estimated -$0.17 by -29.41%, while revenue for the quarter reached $1.53M , beating expectations by +1.93%.
Earnings released on 12 Mar 2025
EPS came in at -$0.19 surpassing the estimated -$0.20 by +5.00%, while revenue for the quarter reached $1.95M , beating expectations by +34.23%.
Earnings released on 12 Nov 2024
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%, while revenue for the quarter reached $1.81M , missing expectations by -1.25%.
Earnings released on 6 Aug 2024
EPS came in at -$0.22 falling short of the estimated -$0.19 by -15.79%, while revenue for the quarter reached $1.74M , missing expectations by -0.06%.
Earnings released on 14 May 2024
EPS came in at -$0.21 falling short of the estimated -$0.15 by -40.00%, while revenue for the quarter reached $1.51M , beating expectations by +9.49%.
Earnings released on 6 Mar 2024
EPS came in at -$0.16 surpassing the estimated -$0.20 by +20.00%, while revenue for the quarter reached $1.76M , beating expectations by +14.35%.
Earnings released on 6 Nov 2023
EPS came in at -$0.15 surpassing the estimated -$0.17 by +11.76%, while revenue for the quarter reached $1.56M , missing expectations by -4.54%.
Earnings released on 8 Aug 2023
EPS came in at -$0.24 falling short of the estimated -$0.17 by -41.18%, while revenue for the quarter reached $1.65M , beating expectations by +6.39%.
Earnings released on 15 May 2023
EPS came in at -$0.53 surpassing the estimated -$0.68 by +22.06%, while revenue for the quarter reached $1.24M , beating expectations by +23.90%.
Earnings released on 30 Mar 2023
EPS came in at -$0.60 falling short of the estimated $0.84 by -171.43%, while revenue for the quarter reached $1.03M , beating expectations by +2.60%.
Earnings released on 8 Nov 2022
EPS came in at -$0.58 surpassing the estimated -$0.73 by +20.55%, while revenue for the quarter reached $1.43M , beating expectations by +2.21%.
Earnings released on 9 Aug 2022
EPS came in at -$0.59 surpassing the estimated -$0.73 by +19.18%, while revenue for the quarter reached $1.53M , beating expectations by +27.58%.
Earnings released on 10 May 2022
EPS came in at -$0.57 surpassing the estimated -$0.80 by +28.75%, while revenue for the quarter reached $1.18M , missing expectations by -15.50%.
Earnings released on 8 Mar 2022
EPS came in at -$0.53 surpassing the estimated -$0.78 by +32.05%, while revenue for the quarter reached $1.38M , beating expectations by +6.15%.
Earnings released on 9 Nov 2021
EPS came in at -$0.53 , while revenue for the quarter reached $1.07M , missing expectations by -10.75%.
Earnings released on 10 Aug 2021
EPS came in at -$0.46 , while revenue for the quarter reached $1.04M , missing expectations by -5.64%.
Earnings released on 11 May 2021
EPS came in at -$0.53 surpassing the estimated -$0.60 by +11.67%, while revenue for the quarter reached $1.01M , missing expectations by -10.45%.
Stock split effective on 27 Apr 2021
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Mar 2021
EPS came in at -$1.50 falling short of the estimated -$0.90 by -66.67%, while revenue for the quarter reached $158.00K .
Earnings released on 9 Nov 2020
EPS came in at -$0.90 surpassing the estimated -$4.20 by +78.57%, while revenue for the quarter reached $980.00K , missing expectations by -33.33%.
NSPR Stock Performance
Access detailed NSPR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.